Seer (NASDAQ:SEER) Shares Down 2.8% – Here’s What Happened

Seer, Inc. (NASDAQ:SEER)’s stock price traded down 2.8% during mid-day trading on Friday . The stock traded as low as $1.76 and last traded at $1.76. 295,349 shares were traded during trading, an increase of 78% from the average session volume of 165,752 shares. The stock had previously closed at $1.81.

Wall Street Analysts Forecast Growth

SEER has been the subject of several research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Seer in a research note on Wednesday, October 8th. Wall Street Zen raised Seer to a “hold” rating in a report on Saturday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Seer Trading Down 2.8%

The business’s fifty day moving average price is $2.08 and its 200 day moving average price is $2.10. The company has a market capitalization of $98.19 million, a P/E ratio of -1.29 and a beta of 1.60.

Seer (NASDAQ:SEER) last posted its quarterly earnings results on Thursday, November 6th. The company reported ($0.32) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.01. The firm had revenue of $4.12 million during the quarter, compared to analyst estimates of $4.00 million. Seer had a negative net margin of 484.51% and a negative return on equity of 25.88%. Equities research analysts anticipate that Seer, Inc. will post -1.42 EPS for the current year.

Insider Activity at Seer

In related news, CEO Omid Farokhzad sold 33,838 shares of the business’s stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $1.97, for a total value of $66,660.86. Following the sale, the chief executive officer owned 1,238,230 shares of the company’s stock, valued at $2,439,313.10. The trade was a 2.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.28% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in SEER. Vanguard Group Inc. lifted its holdings in Seer by 0.9% during the 3rd quarter. Vanguard Group Inc. now owns 2,221,404 shares of the company’s stock valued at $4,820,000 after purchasing an additional 18,760 shares during the last quarter. Bridgeway Capital Management LLC increased its holdings in shares of Seer by 15.5% during the second quarter. Bridgeway Capital Management LLC now owns 837,443 shares of the company’s stock worth $1,792,000 after buying an additional 112,100 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Seer by 16.5% during the second quarter. Geode Capital Management LLC now owns 509,727 shares of the company’s stock worth $1,091,000 after buying an additional 72,265 shares in the last quarter. Jacobs Levy Equity Management Inc. raised its stake in shares of Seer by 124.5% in the first quarter. Jacobs Levy Equity Management Inc. now owns 363,355 shares of the company’s stock valued at $614,000 after acquiring an additional 201,491 shares during the last quarter. Finally, Jane Street Group LLC boosted its holdings in shares of Seer by 33.3% in the 1st quarter. Jane Street Group LLC now owns 254,174 shares of the company’s stock worth $430,000 after acquiring an additional 63,432 shares in the last quarter. 75.20% of the stock is owned by institutional investors.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.